Get the Daily Brief
Latest Biotech News
Health technology assessment debate escalates across borders
A new report from No Patient Left Behind argues that foreign value assessments used by high-income countries such as Canada and Germany systematically undervalue innovative medicines by about 90%....
Biologic platform uses engineered bacterial spores as catalysts
Tufts researchers reported new ways to expand bacterial spores beyond traditional vaccine concepts, using engineered spores as catalysts for chemical reactions and other biomanufacturing...
Oral cancer biology points to circadian vulnerability
Researchers identified how the circadian gene PER2 regulates intracellular cholesterol synthesis in oral squamous cell carcinoma, pointing to a potential chronotherapy angle with simvastatin. The...
Oral squamous cell carcinoma invasion drivers identified
A study in Cell Death Discovery mapped new molecular drivers that shape the invasive margins of oral squamous cell carcinoma. By focusing on how tumors establish and extend invasion at the tissue...
Organoids reveal mitochondrial DNA mutation effects on neurons
Researchers studying human brain organoids reported that mitochondrial DNA heteroplasmy can drive cortical neuronal disturbances, highlighting the m.3243A>G mutation’s link to neurodegenerative...
Clinical evidence on second cancers after T-cell engaging bispecifics
A systematic review and meta-analysis in PubMed pooled safety data on second primary malignant neoplasms after T-cell-engaging bispecific antibody therapy in adults with B-cell non-Hodgkin...
Polyamine therapy explored for Short QT syndrome type 3
Researchers proposed polyamines as a new therapeutic strategy for Short QT Syndrome type 3, a genetic condition associated with short cardiac repolarization and sudden events. The reported...
High-throughput exposure analytics expand EPA tools
The U.S. Environmental Protection Agency unveiled high-throughput approaches through its Exposure Forecasting (ExpoCast) project to better decode chemical exposures in daily life. The work targets...
NK-cell dysregulation linked to heart risk in HIV+ teens
New research highlighted how immune dysregulation in adolescents with perinatally acquired HIV may contribute to cardiovascular disease risk, focusing on NK-cell dysfunction as a driver. The study...
US probes Germany’s drug pricing under Section 301
The U.S. Trade Representative has launched a Section 301 investigation into Germany’s drug pricing policies, arguing the country is effectively leaving the U.S. to shoulder a disproportionate...
No Patient Left Behind challenges foreign HTA valuations
A new report from No Patient Left Behind argues that drug value assessments used outside the U.S. in markets such as Canada and Germany undervalue innovative medicines, claiming the process can...
Safety signal update for T-cell engaging bispecific antibodies
A systematic review and meta-analysis published on PubMed finds that second primary malignant neoplasms (SPMs) occur measurably after T-cell-engaging bispecific antibody therapy used in adult NHL...
Biotech’s next frontier: AI predicts protein-protein interactions at atomic scale
Researchers unveiled a generative AI model designed to predict protein-protein interactions at atomic scale, aiming to improve how scientists identify and engineer binding partners for therapeutic...
Novel biased µ-opioid agonist posts Phase 1 safety data
Early clinical results describe the safety, pharmacokinetics, and pharmacodynamics of SHR8554, a biased µ-opioid receptor agonist evaluated in a Phase I trial. The report positions the program...
AbbVie eyes Apogee acquisition near $11B
AbbVie is reported to be nearing an approximately $11 billion deal for Apogee, signaling continued consolidation in biopharma. The move would extend AbbVie’s footprint by adding Apogee’s...
Obesity drugs tied to testosterone and sperm quality signals
A systematic review presented at the Endocrine Society’s annual meeting in Chicago reports preliminary evidence that GLP-1 receptor–based obesity drugs may increase testosterone levels and improve...
Targeting oral cancer invasion through new molecular drivers
Researchers reported new molecular drivers shaping the invasive margins of oral squamous cell carcinoma (OSCC), a finding published in Cell Death Discovery. The work focuses on how invasion is...
PER2 links circadian biology to cholesterol synthesis for oral cancer
A mechanistic study reports that the circadian gene PER2 can reprogram cholesterol synthesis to block oral cancer progression, with potential implications for chronotherapy. The research describes...
hCG trigger-day exposure linked to neurodevelopmental and epigenetic changes
A study slated for Nature Communications in 2026 reports that human chorionic gonadotropin (hCG) exposure on the trigger day in assisted reproductive technology (ART) can affect DNA methylation...
Regulatory and trade pressure on global drug pricing
The U.S. Trade Representative has launched a Section 301 investigation into Germany’s drug pricing policies, arguing the country leaves the U.S. with a disproportionate burden of global R&D costs....